Document is current
Any future updates will be listed below
-
Authors
Majem, Margarita https://orcid.org/0000-0002-9919-7485
Molina Mata, Kevin
Mayor Ibarguren, Ander
Zafra Poves, Marta
Requena, Celia
Aparisi Aparisi, Francisco de Asis https://orcid.org/0000-0002-1468-1375
Carrera, Cristina https://orcid.org/0000-0003-1608-8820
Blasco Cordellat, Ana https://orcid.org/0000-0001-5889-0382
Freites-Martinez, Azael https://orcid.org/0000-0002-3121-5667
Sanmartin, Onofre
-
Funding
Funding for this research was provided by:
Johnson and Johnson
La Roche Posay
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 22 December 2025
First Online: 28 January 2026
Declarations
:
: MM reports honoraria from Amgen, AstraZeneca, Roche, Bristol Myers Squibb, Merck Sharp & Dohme, Pfizer, Boehringer Ingelheim, Novartis, Immedica, Helsinn Therapeutics, Takeda, Sanofi, Johnson & Johnson, Pierre Fabre, Beigene, Lilly; Research Funding from Bristol-Myers Squibb (Inst), AstraZeneca (Inst), Roche (Inst); travel, accommodations from AstraZeneca, Roche, Pfizer, MSD, Johnson & Johnson. FdAAA reports holding a consultant role at Pfizer and Boehringer Inghelheim, being a speaker for Astra Zeneca, Takeda, and Sanofi, receiving travel expenses from Janssen, Gallecto, Pfizer, Roche, MSD, and Takeda; and others (GIDO). CC reports having received honoraria for speaking for La Roche Posay, ISD, Jonhson and Johnson, as well as travel grants from SANOFI, Pierre Fabre, ISDIN, and BMS. AF-M received support for attending meetings and/or travel from J&J Spain, ISDIN Spain, Galderma Spain; consultancy from SHB Law Firm–Sanofi; and honoraria/educational support from J&J Spain, ISDIN Spain, Galderma Spain, and SHB Law Firm–Sanofi. OS reports being a consultant for Johnson and Johnson, Regeneron, Roche Pharma, Sunpharma and Cantabria Labs. ABC, AMI, KMM, CR, and MZP, have no conflicts of interest to disclose.
: All patients gave informed consent for the publication of their images that illustrate this article.
